Institutional Ownership
Jazz Pharmaceuticals PLC
CUSIP G50871105SHS USDJAZZQ1 2026
13D / 13G Filings
14
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
10.3%
Max % of class reported
Institutional Holders
561
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
14 filings · latest Feb 13, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 10.1% | 6.36M | SEC |
| 2 | Sep 11, 2023 | Vanguard Group Inc | 13G/A | 10.3% | 6.48M | SEC |
| 3 | Feb 9, 2023 | Vanguard Group Inc | 13G/A | 9.6% | 6.05M | SEC |
| 4 | Jan 5, 2023 | Jpmorgan Chase & Co | 13G/A | 4.6% | 2.92M | SEC |
| 5 | Feb 10, 2022 | Vanguard Group Inc | 13G/A | 9.0% | 5.54M | SEC |
| 6 | Feb 10, 2022 | Renaissance Technologies LLC | 13G/A | 2.8% | 1.70M | SEC |
| 7 | Feb 9, 2022 | Fmr LLC | 13G/A | 2.8% | — | SEC |
| 8 | Jan 24, 2022 | Jpmorgan Chase & Co | 13G | 5.2% | 3.25M | SEC |
| 9 | Feb 11, 2021 | Renaissance Technologies LLC | 13G/A | 5.6% | 3.10M | SEC |
| 10 | Feb 10, 2021 | Vanguard Group Inc | 13G/A | 8.8% | 4.88M | SEC |
4 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Jazz Pharmaceuticals PLC.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 5.59M | $1.06B |
| 2 | Capital World Investors | 2.67M | $505.40M |
| 3 | Fmr LLC | 2.28M | $430.23M |
| 4 | Franklin Resources Inc | 1.96M | $370.34M |
| 5 | Dimensional Fund Advisors LP | 1.90M | $358.26M |
| 6 | State Street Corp | 1.89M | $357.62M |
| 7 | Ecor1 Capital, LLC | 1.71M | $322.61M |
| 8 | Bank Of New York Mellon Corp | 1.68M | $317.49M |
| 9 | Fuller & Thaler Asset Management, Inc. | 1.68M | $316.87M |
| 10 | Ameriprise Financial Inc | 1.61M | $304.08M |